Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Ruffell

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cancer Cell|April 17, 2019
Oncogenic KRAS Drives Immune Suppression in Colorectal CancerKay Hänggi, Brian Ruffell
Trends in Immunology|October 30, 2016
Dendritic Cells and Cancer ImmunityAlycia Gardner, Brian Ruffell
Trends in Cancer|February 25, 2023
Cell death, therapeutics, and the immune response in cancerKay Hänggi, Brian Ruffell
Immunity|October 12, 2022
Cytokines drive prostate cancer lineage plasticityJie Li, Brian Ruffell
Nature Cell Biology|June 1, 2017
Reducing interferon'ce in stem cellsAlycia Gardner, Brian Ruffell
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Hyaluronan induces cell death in activated T cells through CD44Brian Ruffell, Pauline Johnson
Biochemical and Biophysical Research Communications|July 9, 2005
Chondroitin sulfate addition to CD44H negatively regulates hyaluronan bindingBrian Ruffell, Pauline Johnson
Inflammation & Allergy Drug Targets|July 16, 2009
CD44 and its role in inflammation and inflammatory diseasesPauline Johnson, Brian Ruffell
Immunity|January 19, 2018
moDCs, Less ProblemsAlycia Gardner, Brian Ruffell
STAR Protocols|November 8, 2025
Protocol for specific induction of apoptosis or necroptosis in established murine tumorsKay Hänggi, Brian Ruffell
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cancer Cell|April 17, 2019
Oncogenic KRAS Drives Immune Suppression in Colorectal CancerKay Hänggi, Brian Ruffell
Trends in Immunology|October 30, 2016
Dendritic Cells and Cancer ImmunityAlycia Gardner, Brian Ruffell
Trends in Cancer|February 25, 2023
Cell death, therapeutics, and the immune response in cancerKay Hänggi, Brian Ruffell
Immunity|October 12, 2022
Cytokines drive prostate cancer lineage plasticityJie Li, Brian Ruffell
Nature Cell Biology|June 1, 2017
Reducing interferon'ce in stem cellsAlycia Gardner, Brian Ruffell
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Hyaluronan induces cell death in activated T cells through CD44Brian Ruffell, Pauline Johnson
Biochemical and Biophysical Research Communications|July 9, 2005
Chondroitin sulfate addition to CD44H negatively regulates hyaluronan bindingBrian Ruffell, Pauline Johnson
Inflammation & Allergy Drug Targets|July 16, 2009
CD44 and its role in inflammation and inflammatory diseasesPauline Johnson, Brian Ruffell
Immunity|January 19, 2018
moDCs, Less ProblemsAlycia Gardner, Brian Ruffell
STAR Protocols|November 8, 2025
Protocol for specific induction of apoptosis or necroptosis in established murine tumorsKay Hänggi, Brian Ruffell
Pageof 7